| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.67B | $5.29B | $5.50B |
| YoY Revenue Growth % | +7.3% | -3.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $168.9M | $165.2M | $296.4M |
| Operating Margin % | 3.0% | 3.1% | 5.4% |
| Net Income (GAAP) | $103.6M | $117.0M | $238.5M |
| EBITDA (Normalized) | $450.5M | $496.4M | $494.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $637.4M | $686.1M | $680.0M |
| Capital Expenditures (CapEx) | $352.0M | $414.0M | $247.5M |
| Free Cash Flow (FCF) | $285.4M | $272.1M | $432.5M |
| FCF Margin % | 5.0% | 5.1% | 7.9% |
| Return on Invested Capital (ROIC %) | 4.2% | 4.0% | 5.9% |
| Cash & Short-Term Equivalents | $201.5M | $117.6M | — |
| Total Debt (Short + Long Term) | $388.4M | $416.3M | $1.54B |
| Total Stockholders' Equity | $3.02B | $2.99B | $3.17B |